Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | ATRA | FIMM | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |